Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical composition for treating plasma cell mastitis as well as traditional Chinese medicine raw material composition

A raw material composition and the technology of the composition are applied in the directions of drug combinations, medical raw materials derived from Ginkgo biloba, medical raw materials from mollusks, etc., which can solve the problems of lack of non-invasive conservative treatment and lack, and reduce adverse drug reactions, The effect of promoting lump reduction

Active Publication Date: 2019-03-12
XIYUAN HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Lack of application of traditional Chinese medicine fixed prescriptions throughout the course of plasma cell mastitis, and lack of non-invasive conservative treatment methods

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0084] The pharmaceutical composition of the present invention can be prepared by conventional preparation methods of traditional Chinese medicine. For example, the preparation method of the decoction includes: putting the above-mentioned Chinese medicine raw materials (for example, in the form of decoction pieces) into a decoction container, and adding water to the decoction container until the Chinese medicine raw materials are covered; Pharmaceutical composition as a decoction.

[0085] In an exemplary embodiment of the present invention, in the step of decocting for a predetermined time, the decoction container may be boiled on high heat and then decocted on low heat for 30 minutes.

[0086] Traditional Chinese medicine external treatment methods include soaking method, fumigation method and so on. Among them, "溻" in the method of soaking is to apply gauze or cotton wool full of medicinal liquid to the affected area, and "溻" means to soak the affected area in medicinal li...

Embodiment 1

[0096] Embodiment 1: decoction and poultice

[0097] Chinese medicine raw materials: raw astragalus 30g, Prunella vulgaris 15g, Shi Jianchuan 10g, Hedyotis 15g, Smilax smilax 15g, Passepartout 15g.

[0098] Preparation method: add to the decoction container, then add water until the above-mentioned raw materials of traditional Chinese medicine are submerged, boil on high heat, then decoct on low heat for 30 minutes, decoct to 200mL each time, filter, and obtain decoction and herbal dregs (ie, dressing ).

Embodiment 2

[0099] Embodiment 2: decoction and poultice

[0100] Chinese medicine raw materials: raw astragalus 60g, Prunella vulgaris 10g, Shi Jianchuan 25g, Hedyotis 20g, Smilax 20g and Passepartout 10g.

[0101] Preparation method: prepare decoction and compress according to the preparation method of Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating plasma cell mastitis as well as a traditional Chinese medicine raw material composition. The pharmaceutical composition is prepared from the following Chinese herbal raw materials in parts by weight: 9 to 60 parts of radix astragali, 10 to 30 parts of spica prunellae, 10 to 50 parts of herba salviae chinensis, 15 to 60 parts of herba hedyotis diffusae, 15 to 60 parts of rhizoma smilacis glabrae and 5 to 20 parts of fructus liquidambaris. The pharmaceutical composition according to the technical scheme of the invention has the effect of replenishing qi to invigorate the spleen, resolving carbuncle and removing stasis, and promoting the blood circulation and removing the toxicity; and moreover, by using the pharmaceutical composition, for those without suppuration, the suppuration can be promoted, for those with suppuration, the ulceration can be promoted, and for those with ulceration, the healing can be promoted. In addition, the pharmaceutical composition according to the invention has no apparent toxic and side effect. In addition, decoction of the invention is cooperated with dressing or ointment of the invention, so that the plasma cell mastitis can be better treated.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, and more specifically, the invention relates to a pharmaceutical composition for treating plasma cell mastitis and a preparation method thereof. Background technique [0002] Plasma cell mastitis (PCM) belongs to the category of non-lactational mastitis. PCM is a nonbacterial inflammatory response caused by obstruction and dilation of mammary ducts, infiltration of plasma cells in the surrounding adipose tissue, ductal wall inflammation, and fibrosis. In the early stage, the skin can be red and swollen, the tumor boundary is clear, the skin temperature rises, and the subareolar abscess can spread to most of the breasts. In the later stage, the abscess can spontaneously rupture and persist, forming a fistula or sinus. Western medicine treatment of this disease mostly chooses treatment methods based on clinical manifestations, such as antibiotic treatment, hormone therapy, ant...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61K36/90A61K36/902A61K36/9066A61P15/14A61K35/32A61K35/618A61K35/64
CPCA61K35/32A61K35/618A61K35/64A61K36/11A61K36/16A61K36/185A61K36/19A61K36/21A61K36/232A61K36/28A61K36/286A61K36/30A61K36/34A61K36/41A61K36/42A61K36/481A61K36/483A61K36/533A61K36/536A61K36/537A61K36/62A61K36/634A61K36/65A61K36/704A61K36/71A61K36/736A61K36/744A61K36/748A61K36/752A61K36/756A61K36/77A61K36/80A61K36/84A61K36/884A61K36/8888A61K36/8945A61K36/896A61K36/8966A61K36/8969A61K36/898A61K36/8994A61K36/90A61K36/902A61K36/9066A61P15/14A61K2300/00
Inventor 张晓军郑丽
Owner XIYUAN HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI